AGTC: The New Leader in Ocular Gene Therapy With Sue Washer (Healio)

AGTC: The New Leader in Ocular Gene Therapy With Sue Washer

Sue Washer, BS, MBA, president and CEO of UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare retinal diseases, discusses with Joshua Mali, MD, host of the Eye Care Insider Podcast by Healio, about gene therapy in ophthalmology, AGTC’s clinical trial progress, as well as current and future challenges faced by both the cell therapy industry and ophthalmology.

Learn more about AGTC: The New Leader in Ocular Gene Therapy With Sue Washer.
X